siRNA, Anti-Human NAT2, LNA(CAT#: SIRGT04004WQ-LNA)

The product SIRGT04004WQ-LNA is a type of small interfering RNA (siRNA) that targets NAT2 gene and regulates the expression of gene. The siRNA interferes with the expression of NAT2 genes with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000015.2
Alternative Names AAC2; PNAT; NAT-2
Related Diseases Bladder cancer, Breast cancer
Purification HPLC
Target Gene
Gene ID 10
Uniprot ID P11245

Related Products